Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001013762-14-001206
Filing Date
2014-10-09
Accepted
2014-10-09 16:58:40
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO QUARTERLY REPORT f10q0314a1_intellicell.htm 10-Q/A 823720
2 EXHIBIT 31.1 ex311.htm EX-31.1 12254
3 EXHIBIT 31.2 ex312.htm EX-31.2 12254
4 EXHIBIT 32.1 ex321.htm EX-32.1 5211
5 EXHIBIT 32.2 ex322.htm EX-32.2 4883
  Complete submission text file 0001013762-14-001206.txt   6234853

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE svfc-20140331.xml EX-101.INS 1110292
7 XBRL SCHEMA FILE svfc-20140331.xsd EX-101.SCH 49746
8 XBRL CALCULATION FILE svfc-20140331_cal.xml EX-101.CAL 53022
9 XBRL DEFINITION FILE svfc-20140331_def.xml EX-101.DEF 116619
10 XBRL LABEL FILE svfc-20140331_lab.xml EX-101.LAB 270259
11 XBRL PRESENTATION FILE svfc-20140331_pre.xml EX-101.PRE 214536
Mailing Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021
Business Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021 (212) 249-3050
Intellicell Biosciences, Inc. (Filer) CIK: 0001125280 (see all company filings)

EIN.: 911966948 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54729 | Film No.: 141150584
SIC: 2836 Biological Products, (No Diagnostic Substances)